ROCKVILLE, MD, May 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, announced today the appointment of four world-renowned experts to the company’s newly created Scientific Advisory Board (SAB). Members of the Board will serve as a key resource to Therabron as the company pursues the development and ultimate commercialization of new therapies to treat a range of neglected and underserved respiratory conditions.

For more information, read here.